Cookie Policy - To find out more about cookies on this website, see our privacy policy

Cookie Policy

We Help Companies Find New Sales Opportunities

We Help Companies Find New Sales Opportunities

Shield Diagnostics


Shield Diagnostics is planning to acquire Axis Biochemicals of Norway for £67m, which will enable the two companies to jointly develop tests for assessing the risk of heart disease.
19-Jan-1999